World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 13 January 2015
Main ID:  ISRCTN37562266
Date of registration: 13/04/2005
Prospective Registration: No
Primary sponsor: Oxford Radcliffe Hospitals NHS Trust (UK)
Public title: The effects of Modafinil on functional magnetic resonance imaging (fMRI) brain activation and functional performance during visual stimulation and visually guided tracking manoeuvres after sleep deprivation
Scientific title:
Date of first enrolment: 01/08/2004
Target sample size: 30
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN37562266
Study type:  Interventional
Study design:  Randomised controlled trial (Other)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Robert J.O    Davies
Address:  Consultant in Respiratory Medicine Oxford Centre for Respiratory Medicine Churchill Hospital Headington OX3 7LJ Oxford United Kingdom
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 30 Healthy volunteers between the ages of 18-65
Exclusion criteria: Previous neurological disease

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
N/A
Nervous System Diseases
Sleep disorders
Intervention(s)
Please note that as of 16/09/09 the status of this trial has been changed to "Stopped" due to relocation of primary investigator (PI) and lack of funding.

Each subject will be scanned 3 times, the first as a baseline, after normal sleep, and then twice after sleep deprivation, following treatment with Modafinil or placebo, in random order. Within each scanning session the subject will perform a series of hand/eye tracking tests of varying difficulty in random order, and a global visual stimulation test. Following the scans objective sleepiness will be quantified from the OSLER test of subjective sleepiness and steering ability will be quantified from the Oxford Steering Simulator. Subjects will be pre-trained to stable performance on the tracking task prior to fMRI scanning.
Primary Outcome(s)
The primary endpoint of the trial is the difference in activation of the occipital visual cortex area responsible motion detection (V5/MT) during global visual stimulation after Modafinil and placebo
Secondary Outcome(s)
Sleep latency (measured by the OSLER test), driving simulator performance and tracking error will be secondary endpoints
Secondary ID(s)
C03.056
Source(s) of Monetary Support
Cephalon UK Ltd (UK) (ref: Davies2004/unrestricted grant)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history